The structure of the Rous sarcoma virus envelope glycoprotein complex was studied by sedimentation gradient centrifugation analyses of detergent-solubilized wildtype and mutant envelope (env) gene products. These studies show that the envelope glycoprotein forms an oligomer during biosynthesis, which is most likely a trimer, and that this is the form of the complex found in virions. Our results are consistent with oligomer formation and transport out of the endoplasmic reticulum being closely linked. From analyses of mutant envelope proteins we conclude that the extracellular domain of the glycoprotein is sufficient for oligomer formation but that the transmembrane domain is required to stabilize this complex. Additional experiments suggest that interactions between external domains of the membrane-spanning, gp37 polypeptides are those most important for the formation of trimers. The significance of these observations to retroviral replication and implications for antiviral drug development are discussed.
Retroviral envelope glycoproteins play an essential role in initiation of infection by binding to a specific receptor on susceptible cells. They also play a major role in fusion of the viral membrane with a cellular membrane so that capsids can be released into the target cell cytoplasm. In addition, the envelope proteins must be compatible with the intracellular transport, allowing the proteins to be directed to the plasma membrane where virus is formed by budding.
One aspect of the structure of envelope proteins that might play an essential role in these various interactions is the formation of an oligomeric complex. The hemagglutinin (HA) of influenza virus has been shown to exist as a trimer by chemical crosslinking and x-ray crystallography (1, 2) . Pulsechase experiments designed to follow trimer formation within cells suggested that formation of the trimer was required for intracellular transport (3) . Similar experiments with the vesicular stomatitis virus (VSV) G glycoprotein indicate that it too forms a trimer (4) and that its transport from the endoplasmic reticulum (ER) is also dependent on oligomer formation (5) . These results are consistent with what has been observed for a number of cellular proteins, such as the class I and class II major histocompatibility molecules and the T-cell receptor, that are present at the cell surface as part of a multichain complex (6) (7) (8) . The individual polypeptide chains of these heterooligomers are not effectively transported from the ER to the cell surface unless they first associate in an oligomeric complex with the other proteins. The precise molecular basis of this apparent connection between oligomerization and transport has not been elucidated.
The trimeric structure of the viral envelope glycoproteins may also be involved in their fusogenic activities. The HA protein undergoes a pH-induced conformational change that exposes the normally sequestered hydrophobic fusion peptide, consistent with virus-cell membrane fusion occurring within the acidic environment of the endosome (9) (10) (11) . The conformational change appears to primarily involve an alteration in the relative orientation and association of the monomers, which individually retain their secondary structure (10) .
We have investigated the oligomeric nature of the Rous sarcoma virus (RSV) envelope glycoprotein complex to better understand the structure of this molecule and to determine whether oligomerization constitutes an essential stage in its biosynthetic pathway. The intracellular transport and processing of the RSV envelope (env) gene product has been analyzed in previous studies using a simian virus 40 (SV40)-based vector to express the protein in the absence of other RSV components (12) (13) (14) . Translation of the env gene produces a 95-kDa core glycosylated precursor (Pr95) that is terminally glycosylated and proteolytically cleaved in the Golgi compartment (15, 16) . The mature env gene product is a disulfide-linked complex of two glycoproteins, gp 85 and gp37. By using sedimentation gradient centrifugation, we have found that the RSV envelope protein forms an oligomer during biosynthesis, which is most likely a trimer, and that this is the form of the complex found in virions. Results from the analysis of mutant envelope proteins indicate that the extracellular domain of the complex is sufficient for oligomerization but that the transmembrane domain is required to stabilize the complex. A mutant protein that does not form an oligomer is not transported out of the ER. Treatment of intact virus with reducing agents releases gp85 monomers from the virion but leaves the gp37 molecules in trimeric structures, suggesting that interactions between gp37 molecules may be most important for the formation of trimers.
MATERIALS AND METHODS Cells, Viruses, and Vectors. For the majority of the experiments described here, wild-type and mutant envelope glycoprotein genes of RSV were expressed from a late replacement SV40 vector (SV.env.KX) in CV-1 cells as described (12, 14) . The construction and phenotypic characterization of the mutant RSV env genes employed in the studies below have been described [mutants C3 (12) , X1 (17) , and T(-) and A(-) (18) ]. The HA and neuraminidase (NA) genes of influenza virus, cloned into similar SV40 vectors (19, 20) 15-min incubation at room temperature. The immune complexes were pelleted, washed, and prepared for NaDodSO4/PAGE as described (14) .
Secreted envelope proteins were labeled as above but the pulse period was extended to 20 min followed by a 2-hr chase at 37°C. A 1-ml aliquot of the culture medium was adjusted to 40 mM octyl glucoside and centrifuged for 5 min at 4°C in a microcentrifuge before application to the sucrose gradient.
Labeling of Virus Proteins. RSV-PrC-infected primary turkey embryo cells in 60-mm plates were incubated for 60 min in leucine-free DMEM that was then replaced with 500 ,41 of the same medium containing 400 ,Ci of [3H]leucine (57 Ci/mmol; Amersham). After 60 min at 37°C, 2 ml of complete medium was added and cells were incubated at 37°C for an additional 14 hr. The culture medium was collected and centrifuged at 4°C for 5 min in a microcentrifuge. Aliquots of 600 ul were supplemented with octyl glucoside to 40 mM, incubated 10 min on ice, and loaded on sucrose gradients as above.
To determine the oligomeric nature of gp85 and gp37 following dissociation of the two molecules by reducing agents, virus was lysed in the presence of 30 mM dithiothreitol prior to sedimentation in sucrose gradients made in OGL buffer containing 10 mM dithiothreitol.
RESULTS
RSV env Gene Product Forms an Oligomer Posttranslationally. To determine whether the glycoprotein of this prototype retrovirus is arranged in an oligomeric structure, we took advantage of an approach used by Gething et al. (3) to characterize formation of the influenza virus HA trimer during the biosynthesis and intracellular transport of that glycoprotein. This sedimentation analysis makes use of the observation that multimeric molecules are initially synthesized as monomeric subunits that assemble posttranslationally. Thus, pulse-labeled products sediment in sucrose gradients with a velocity equivalent to the mass of the monomer, whereas with increasing chase times these proteins associate and sediment with a velocity proportional to the mass of the multimer.
When cells expressing the RSV envelope protein were lysed immediately after pulse-labeling of cells, the bulk of the 95-kDa precursor (Pr95) was detected in fraction 14 ( Fig. 1A) . However, after a 60-min chase a significant proportion of Pr95 was immunoprecipitated from fractions 6-8 ( and the mature, terminally glycosylated cleavage products of the RSV env gene, gp85 and gp37, were detected in fraction 4. Thus, the RSV envelope protein exhibited a discrete change in mass during the chase period that was analogous to that described for the HA of influenza virus and was consistent with formation of an oligomer of a specific size. Oligomerization of the envelope protein after a 30-min chase was less complete than that observed with the HA protein analyzed in parallel gradients (data not shown). We therefore performed a series of chase experiments to assess the rate of oligomerization. These experiments (data not shown) indicated that the ti/2 for oligomerization is =80 min, a result that is consistent with the long time interval required for the RSV glycoprotein to move from the ER to the Golgi complex ref. 12; see below). No gp85 or gp37 was detected in the monomeric range of the gradient suggesting that cleavage of the precursor occurs in the oligomer and that it remains stable as it moves to the cell surface, where the bulk of the gp85 and gp37 is found.
The RSV Envelope Complex is Most Likely a Trimer. Since virus and cellular glycoproteins appear to assemble into a number of distinct multimeric forms, it was important to define the nature of the envelope oligomer. We therefore calibrated the sucrose gradients used in these studies by sedimenting the pulse and pulse-chase products of the HA (a trimer) and NA (a tetramer) genes of influenza virus in parallel gradients (Fig. 2) . The RSV Pr95 oligomer appears to be larger than the HA trimer (-210 kDa), since it sedimented faster in the gradients. On the other hand, both the NA oligomer and the RSV oligomer sedimented to the same fractions in these gradients, and the estimated size of a Pr95 trimer (285 kDa) agrees well with that of the NA tetramer (=270 kDa). There is a direct correlation between the sedimentation rate of the influenza virus polypeptides (and their well-defined oligomers) and their molecular mass (Fig.  2) . By extrapolating from the position in the gradient of the mature gp85/gp37 complex on this linear plot, we calculated a molecular mass of -360 kDa for the terminally glycosylated complex. This value is consistent with the mature envelope glycoprotein complex of RSV being a trimeric structure, since the sum molecular mass of gp85 and gp37 is -120 kDa (16 CV-1 cells were infected with SV40 recombinant stocks expressing influenza HA or NA or the RSV env gene product. Cells were pulse-labeled for 5 min and lysed either immediately or after a 1-hr chase prior to sedimentation analyses. The monomeric and oligomeric forms (both precursor and mature products) of the influenza gene products were identified by immunoprecipitation and their positions on the gradient were plotted against their estimated molecular masses. Closed circles indicate the position in parallel gradients of the pulse-labeled (Pr95 monomer) and pulse-chase (Pr95 'trimer' and mature 'trimer') RSV env products. All estimated molecular masses are based on subunit apparent molecular mass determined from NaDodSO4/polyacrylamide gel electrophoresis (10% gels).
of HA or VSV G proteins from the ER. In preliminary experiments, where cells were held on ice for a period of time following the pulse and then lysed, we observed the formation of Pr95 trimers. This contrasts with the results obtained when cells were lysed immediately after the pulse (Figs. lA  and 3A) . The results of such an experiment where cells were pulse-labeled and then lysed immediately (Fig. 3A) , lysed after 1 hr on ice (Fig. 3B) , or lysed after a 1 hr chase in nonradioactive medium at 37°C (Fig. 3C) clearly show that -=20% of the Pr95 synthesized in the pulse associates into trimeric molecules at 0°C. As we will discuss below, this suggests that association of monomers into trimeric structures can occur in the ER very soon after translation.
Previous reports (12, 17) 4-gp85 C abnormal transport behavior were analyzed to investigate the relationship between oligomerization and intracellular location. Mutant C3 has a deletion of the region encoding the carboxyl terminal 95 amino acids of gp37, a truncation that encompasses 46 external amino acids of gp37 along with the entire transmembrane and cytoplasmic domains. This mutant has been shown to accumulate in a stable manner in the ER, apparently due to a block in transport (12) . This protein did not form any detectable trimers during a 1-hr chase (Fig. 4 A  and B) . The X1 mutant protein, on the other hand, has a deletion that results in the loss of amino acids 4-17 at the aminoterminus of gp85, and the modified Pr95 is transported out of the ER but accumulates in a pre-Golgi compartment; it is not cleaved or terminally glycosylated (17) . Unlike the C3 mutant, the X1 mutant readily formed trimeric molecules during a chase (Fig. 4 C and D) but, as might be expected from its previously described phenotype, only Pr95 trimers were observed; no mature products were seen even with prolonged chases at 37°C.
External Domain of the Envelope Complex Is Sufficient for Trimerization. Since the RSV envelope glycoprotein is a transmembrane protein, its oligomerization could involve interactions between the cytoplasmic domains, the transmembrane regions, the extracellular domain, or a combination of these. Previously characterized envelope mutants (18) lacking the cytoplasmic domain [T(-)] or both the cytoplasmic and transmembrane domains [A(-)] were analyzed for oligomerization. In the T(-) mutant the arginine codon at the intracellular boundary of the transmembrane region has been modified to a stop codon. This protein is synthesized and transported to the cell surface with normal kinetics and can be efficiently incorporated into and confer infectivity on nascent virions (18) . As might be expected from these wild-type properties, this mutant protein was observed to form trimers in a wild-type manner (data not shown). The A(-) envelope protein is a soluble form of the env gene product in which the lysine codon at the extracellular boundary of the transmembrane coding region has been changed to a stop codon. The A(-) "Pr95" also trimerized at a rate similar to that of wild type, but the gp85/"gp37" complex was not seen in cell lysates due to its rapid secretion from the cells (Fig. 5 A and B) . The secreted A(-) protein was predominantly monomeric when analyzed in sucrose gradients containing octyl glucoside, although some of the covalently linked gp85/"gp37" complex together with some uncleaved envelope precursor were immunoprecipitated from fractions of the gradient, consistent with their having oligomeric structure (Fig. SC, lanes 7 and 8) . It 37TC (B) . In C, culture medium was collected after a 20-min pulse-labeling and 2-hr chase at 37TC. Lysates and medium were analyzed as in Fig. 1 . not clear whether this is the form the protein assumes after secretion or whether it results from the detergent treatment or sucrose gradient centrifugation. It should be noted that in contrast to membrane-anchored molecules, the soluble gp85/"gp37" complex was found in all the fractions between those containing trimers and the monomers, suggesting that dissociation during centrifugation may indeed have occurred. Most important, the A(-) envelope protein clearly has the ability to form trimers intracellularly, indicating that this domain is sufficient to initiate the oligomerization event.
Since the mature trimer is less stable than the membraneanchored form, the membrane-spanning anchor domain may thus play an important role in stabilizing the trimer structure.
Envelope Complex in Virions Is Trimeric. To determine whether the envelope oligomer is the functional form found in virions, turkey cells infected with a molecular clone of RSV strain PrC were labeled with [3H]leucine. Virus released into the culture supernatant was lysed by addition of octyl glucoside detergent and the soluble proteins were analyzed by sucrose gradient fractionation (Fig. 6A) . The detergentextracted envelope glycoprotein complex and the cellassociated glycoprotein migrated in an identical fashion (fractions 4 and 5), indicating that the envelope protein complex exists as a trimer in the viral membrane.
To investigate the relative roles of gp37 and gp85 in trimer formation, we treated virus with reducing agent. This has been shown to result in the loss ofgp85 from virions (together with concomitant loss of infectivity), while gp37 remains virus-associated (23) . Fig. 6B shows that when virus was treated with 30 mM dithiothreitol prior to sedimentation in octyl glucoside/sucrose gradients, the trimer observed in Fig. 6A was disrupted and gp85 sedimented as a monomer (fractions 15 and 16). In contrast, gp37 was immunoprecipitated from fractions 11-14, demonstrating a sedimentation rate consistent with a mass exceeding 100 kDa and thus with it retaining its trimeric associations. This result, taken together with the results obtained with the A(-) form of the env gene product, point to an important role for the extracellular domain of gp37 in trimer assembly.
DISCUSSION
Our analysis of the RSV envelope complex by sedimentation in sucrose gradients has shown that the env gene product is arranged in an oligomer that forms shortly after synthesis of the polypeptides. The oligomer was detected in specific fractions of the gradient, indicating that it is of a discrete size. Indeed, a comparison of the sedimentation of the RSV envelope oligomer with that of the HA and NA oligomers of influenza virus in parallel gradients supports the conclusion that this retroviral glycoprotein is in a trimeric structure. It should be noted that solubilized monomers do not associate into an oligomer, the oligomer forms only during a further incubation of pulse-labeled cells. The trimeric form is the only form of the glycoprotein present in virions and its size appears to be identical to that detected in CV-1 cells where it is expressed from an SV40 vector. Thus, capsid proteins do not appear to remain associated with the glycoproteins under the detergent conditions employed here. Previous studies (24, 25) employing chemical crosslinking of virion proteins failed to detect a discrete oligomeric form of the RSV glycoprotein, although Pepinsky et al. (24) did report the presence of a larger form of the glycoproteins after crosslinking. Both studies may have been complicated by additional crosslinking of the glycoproteins to internal virion structural proteins (25) .
Our results are consistent with trimer formation being required for transport out of the ER. The C3 protein does not get transported out of the ER and does not form a trimer, whereas the mutants transported out of the ER form trimers at a rate comparable to that ofthe wild-type protein. The RSV envelope protein is transported to the Golgi compartment more slowly than the HA and VSV G proteins (6) . We have observed that the rate of oligomerization of the RSV protein is also slower than those reported for HA and G, and the lack of an accumulation of Pr95 trimers in the ER is consistent with oligomerization being the rate-limiting step. In addition, a significant level of Pr95 trimer forms during a 60-min period at 0°C, indicating that transport is not required for oligomerization. The latter result suggests that lateral diffusion within the membrane is not the rate-limiting factor in trimer formation; it seems likely that association of monomers occurs shortly after translation but that the formation of a detectable trimer may be dependent on additional intra-and intermolecular interactions. Trimer formation itself is not likely to be a transport signal but may be required for expression of a transport signal. Alternatively, an aspect of the monomer may interfere with transport and need to be masked by association in the trimer. A mutant envelope protein lacking the transmembrane and cytoplasmic domains was found to be capable of forming trimers ofPr95. Previous studies have shown that this protein is efficiently secreted from expressing cells as a gp85/"gp37" complex that is processed in a manner analogous to the processing of the wild-type protein, although it is not membrane-bound. The A(-) protein secreted into culture medium was detected primarily as monomeric gp85/"gp37" although some oligomeric gp85/"gp37" as well as "Pr95" trimer were also observed. While the extracellular domain of the RSV envelope protein is capable of forming a trimer, restriction of the mobility of its carboxyl-terminal end or additional interactions between transmembrane regions may be necessary to stabilize the complex. Failure of the A(-) protein to form detectable trimers during a 60-min chase at 0C (data not shown) also suggests a supporting role for the transmembrane region or for membrane attachment per se.
The results of gradient sedimentation analysis of the virion envelope complex under reducing conditions together with the A(-) protein results, point to a major role for the extracellular domain of gp37 in trimer formation. The release of monomeric gp85 and retention of trimeric gp37 after exposure to dithiothreitol are consistent with previous studies in which gp85 was released from virions under reducing conditions (23) . The envelope protein complex appears as a "knobbed spike" in electron micrographs of virions (26), reflecting a structure in which the knob consists primarily of gp85, while gp37 forms the membrane-spanning spike (23, 26) . Our results suggest that three gp37 molecules tightly associate to form the spike, whereas the three gp85 molecules in the knob are more loosely associated. The C3 mutant, which fails to trimerize, lacks 46 external amino acids along with the adjacent transmembrane and cytoplasmic domains. While such a major deletion could have extensive effects on conformation, this result is at least consistent with gp37 playing a major role in trimer formation.
The envelope glycoproteins of different retroviruses show significant conservation in the organization oftheir structural domains, topology, and function (27) . It is therefore likely that these important structural proteins in viruses such as human immunodeficiency virus will, like the RSV env gene product, be arranged in trimers. The envelope glycoproteins of retroviruses must be capable of inducing fusion of cell membranes, since this process has to occur before the viral capsid can enter the cytoplasm. In the influenza virus HA the short hydrophobic region at the amino terminus of HA2 is sequestered within the HA trimer until, at low pH, a conformational change required for fusion activity allows presentation of this sequence to the membrane. A possible fusogeenic sequence is present in the extracellular domain of the RSV gp37 (28) , and it is conceivable that this apolar sequence is hidden in the core of the trimer complex. Indeed, viral envelope glycoproteins may utilize a trimeric structure to carry a fusogenic sequence in a latent form to avoid abortive expression of that activity prior to virus release. The trimer could also be advantageous by providing a more rigid structure (2, 5) or by increasing the avidity of cell binding. Compounds capable of destabilizing the trimer or of preventing its disassembly might thus be potent antiretroviral agents.
